Moises J. Velez

3.2k total citations
14 papers, 316 citations indexed

About

Moises J. Velez is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Moises J. Velez has authored 14 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Epidemiology. Recurrent topics in Moises J. Velez's work include Neuroendocrine Tumor Research Advances (5 papers), Lung Cancer Research Studies (5 papers) and Neuroblastoma Research and Treatments (3 papers). Moises J. Velez is often cited by papers focused on Neuroendocrine Tumor Research Advances (5 papers), Lung Cancer Research Studies (5 papers) and Neuroblastoma Research and Treatments (3 papers). Moises J. Velez collaborates with scholars based in United States and Japan. Moises J. Velez's co-authors include Matthew D. Hellmann, Valerie W. Rusch, Jamie E. Chaft, William D. Travis, Nitin Roper, Nobuyuki Takahashi, Deborah Mulford, Anish Thomas, Stephen M. Hewitt and Jane B. Trepel and has published in prestigious journals such as Nature Communications, The Journal of Immunology and The Annals of Thoracic Surgery.

In The Last Decade

Moises J. Velez

13 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Moises J. Velez United States 7 234 114 95 85 40 14 316
Dian Ren China 12 136 0.6× 165 1.4× 55 0.6× 95 1.1× 17 0.4× 26 325
Yael Steinberg‐Silman Israel 7 307 1.3× 56 0.5× 48 0.5× 70 0.8× 74 1.9× 8 373
Nancy Bailey United States 6 335 1.4× 112 1.0× 59 0.6× 69 0.8× 90 2.3× 8 409
Zhong-Guo Zhou China 11 196 0.8× 77 0.7× 75 0.8× 62 0.7× 122 3.0× 17 387
Sunao Ushijima Japan 9 171 0.7× 116 1.0× 51 0.5× 156 1.8× 15 0.4× 14 349
Go Makimoto Japan 10 147 0.6× 193 1.7× 21 0.2× 81 1.0× 26 0.7× 60 298
Amanda Goldrick Australia 8 166 0.7× 46 0.4× 33 0.3× 83 1.0× 16 0.4× 11 245
Edwin A. Basak Netherlands 10 318 1.4× 92 0.8× 44 0.5× 52 0.6× 126 3.1× 18 403
Norimitsu Kasahara Japan 10 196 0.8× 163 1.4× 30 0.3× 40 0.5× 26 0.7× 29 301

Countries citing papers authored by Moises J. Velez

Since Specialization
Citations

This map shows the geographic impact of Moises J. Velez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moises J. Velez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moises J. Velez more than expected).

Fields of papers citing papers by Moises J. Velez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moises J. Velez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moises J. Velez. The network helps show where Moises J. Velez may publish in the future.

Co-authorship network of co-authors of Moises J. Velez

This figure shows the co-authorship network connecting the top 25 collaborators of Moises J. Velez. A scholar is included among the top collaborators of Moises J. Velez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moises J. Velez. Moises J. Velez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Nkosi, Dingani, William Crowe, Brian J. Altman, et al.. (2024). SATB2 is an Emergent Biomarker of Anaplastic Thyroid Carcinoma: A Series with Comprehensive Biomarker and Molecular Studies. Endocrine Pathology. 35(4). 432–441. 1 indexed citations
2.
Kim, Yongsoo, Barzin Y. Nabet, Huann‐Sheng Chen, et al.. (2024). MA17.11 NOTCH1 Expression Is Associated with Overall Survival in Small Cell Lung Cancer Patients Treated with Atezolizumab in IMpower133. Journal of Thoracic Oncology. 19(10). S127–S127.
3.
Zhang, Huina, et al.. (2024). HER2 evaluation for clinical decision making in human solid tumours: pearls and pitfalls. Histopathology. 85(1). 3–19. 12 indexed citations
4.
Karakaş, Cansu, Ellen Giampoli, Tanzy Love, David G. Hicks, & Moises J. Velez. (2024). Validation and interpretation of Pan-TRK immunohistochemistry: a practical approach and challenges with interpretation. Diagnostic Pathology. 19(1). 10–10. 5 indexed citations
5.
6.
Roper, Nitin, et al.. (2023). Exploration of HER2 (ERBB2) immunohistochemistry in non-small cell lung cancer: correlation with ERBB2 mutational status: experimental research. Annals of Medicine and Surgery. 85(6). 2640–2646. 4 indexed citations
7.
Lissa, Delphine, Nobuyuki Takahashi, Parth Desai, et al.. (2022). Heterogeneity of neuroendocrine transcriptional states in metastatic small cell lung cancers and patient-derived models. Nature Communications. 13(1). 2023–2023. 60 indexed citations
8.
Chen, Irene Y., et al.. (2022). Imaging and Clinical Findings in a Series of Six Cases of Rare Primary Mediastinal Liposarcoma. Radiology Cardiothoracic Imaging. 4(2). e210259–e210259. 5 indexed citations
9.
Roper, Nitin, Moises J. Velez, Alberto Chiappori, et al.. (2021). Notch signaling and efficacy of PD-1/PD-L1 blockade in relapsed small cell lung cancer. Nature Communications. 12(1). 3880–3880. 106 indexed citations
10.
Chen, Irene Y., et al.. (2021). Poorly differentiated neuroendocrine carcinomas of the gastrointestinal tract: A single-institute study of 43 cases. Pathology - Research and Practice. 226. 153614–153614. 10 indexed citations
11.
Komisarof, Justin, Haoming Qiu, Moises J. Velez, & Deborah Mulford. (2020). Anterior mediastinal large cell neuroendocrine carcinoma with elevated AFP: A case report and review. Molecular and Clinical Oncology. 14(2). 34–34. 1 indexed citations
12.
13.
Vardhana, Santosha A., et al.. (2018). Strategies for Recognizing and Managing Immune-Mediated Adverse Events in the Treatment of Hodgkin Lymphoma with Checkpoint Inhibitors. The Oncologist. 24(1). 86–95. 8 indexed citations
14.
Chaft, Jamie E., Matthew D. Hellmann, Moises J. Velez, William D. Travis, & Valerie W. Rusch. (2017). Initial Experience With Lung Cancer Resection After Treatment With T-Cell Checkpoint Inhibitors. The Annals of Thoracic Surgery. 104(3). e217–e218. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dian Ren Breakdown of academic impact, for papers by Yael Steinberg‐Silman Breakdown of academic impact, for papers by Nancy Bailey Breakdown of academic impact, for papers by Zhong-Guo Zhou Breakdown of academic impact, for papers by Sunao Ushijima Breakdown of academic impact, for papers by Go Makimoto Breakdown of academic impact, for papers by Amanda Goldrick Breakdown of academic impact, for papers by Edwin A. Basak Breakdown of academic impact, for papers by Norimitsu Kasahara
Rankless by CCL
2026